Live from the NIH registry
Studies recruiting near Champaign right now
Top 25 of 167 recruiting studies, sorted by proximity — each links to its official registry page
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Alcohol After Bariatric Surgery 2
Sleeve Gastrectomy
N/A
Observational 88 participants sought
University of Illinois at Urbana Champaign — Urbana, Illinois (3.5 mi)
· Sponsor: University of Illinois at Urbana-Champaign
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 600 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Breast Neoplasms
Phase 3
Interventional 558 participants sought
Carle Foundation Hospital d/b/a Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: BioNTech SE
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
Chronic Kidney Disease and Hypertension
Phase 2
Interventional 218 participants sought
Research Site — Champaign, Illinois (1.6 mi)
· Sponsor: AstraZeneca
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Brain Metastases
Phase 3
Interventional 206 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Canadian Cancer Trials Group
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
An Individualized-health eLibrary App for People With Multiple Sclerosis
Multiple Sclerosis
N/A
Interventional 60 participants sought
University of Illinois Urbana-Champaign — Champaign, Illinois (1.6 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Wake Forest University Health Sciences
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
Locally Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma
Phase 2
Interventional 122 participants sought
Carle Cancer Center NCI Community Oncology Research Program — Urbana, Illinois (3.5 mi)
· Sponsor: Academic and Community Cancer Research United
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast Cancer, Locally Advanced Breast Cancer
Phase 3
Interventional 1,000 participants sought
Clinical Trial Site — Urbana, Illinois (3.5 mi)
· Sponsor: Olema Pharmaceuticals, Inc.
Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms
Alcohol Drinking, Alcohol Intoxication
N/A
Observational 240 participants sought
University of Illinois at Urbana-Champaign — Champaign, Illinois (1.6 mi)
· Sponsor: University of Illinois at Urbana-Champaign
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
Interventional 359 participants sought
Research Site — Champaign, Illinois (1.6 mi)
· Sponsor: AstraZeneca
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
Optimized Tailored Interventions in Metabolic and Lifestyle Outcomes (OPTIMAL)
Cognitive Change, Diet, Healthy
N/A
Interventional 72 participants sought
University of Illinois at Urbana-Champaign — Urbana, Illinois (3.5 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer, Cognitive Impairments
N/A
Interventional 386 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Phase 3
Interventional 466 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Extensive Stage Lung Small Cell Carcinoma
Phase 2, Phase 3
Interventional 138 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)